Download Your Complimentary Copy of the 2026 Agenda
The 10th Complement-Based Drug Development Summit is your unique forum to learn, network and partner with the brightest minds revolutionizing the complement therapeutics.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
What's New for 2026?
The Complement-Based Drug Development Summit returns for its 10th year with refreshed content designed to help developers navigate the next era of complement therapeutics. As the field expands beyond C3 and C5 inhibition, the 2026 agenda explores emerging targets, novel modalities, and new opportunities across ophthalmology, neurodegeneration, oncology, autoimmune disease, and beyond:
- Expanded focus on next-generation complement targets, including Factor B, Factor H and C1q
- Broader discussion of complement approaches across CNS, ocular, oncology and autoimmune indications
- New speaker perspectives from emerging biotech innovators and researchers
- Enhanced coverage of siRNA, gene therapy, biologics and small molecule approaches
- Interactive workshops focused on target selection and modality strategy
New Companies on the 2026 Agenda:
80+
Experts Dedicated to Complement
18+
Data-Driven Presentations
7+
Hours of In-Person Networking
2
Discussed-Led, Interactive Workshops
1
Scientific Poster Session